Literature DB >> 10560276

Interaction of fluvoxamine with warfarin in an elderly woman.

K B Yap1, S T Low.   

Abstract

An 80-year-old woman presented with an embolic stroke secondary to atrial fibrillation and mitral stenosis. She was initially on intravenous heparin and was subsequently maintained on oral warfarin. She was also given digoxin for atrial fibrillation and colchicine for gouty arthritis as well as fluvoxamine in her fourth week in hospital, to treat her depression. However, her INR (international normalised ratio) became markedly elevated within a week. Fluvoxamine and warfarin were stopped immediately. When warfarin was reintroduced 6 days later, her INR value increased again. The coagulation profile only became stable after 2 weeks of cessation of fluvoxamine. Low dose fluvoxamine can interact significantly with warfarin in the elderly and the effect may persist for up to 2 weeks of stopping the antidepressant.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10560276

Source DB:  PubMed          Journal:  Singapore Med J        ISSN: 0037-5675            Impact factor:   1.858


  9 in total

Review 1.  Clinically significant drug interactions with newer antidepressants.

Authors:  Edoardo Spina; Gianluca Trifirò; Filippo Caraci
Journal:  CNS Drugs       Date:  2012-01-01       Impact factor: 5.749

2.  Can colchicine potentiate the anticoagulant effect of fluindione?

Authors:  Valérie Gras-Champel; Patrick Ohlmann; Elisabeth Polard; Marie-Louise Wiesel; Jean-Louis Imbs; Michel Andréjak
Journal:  Eur J Clin Pharmacol       Date:  2005-07-09       Impact factor: 2.953

3.  Pharmacovigilance--Current and Future Challenges. Abstracts of the International Society of Pharmacovigilance annual conference. Dublin, Ireland, 6-8 October 2004.

Authors: 
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

Review 4.  Clinically significant drug interactions with antidepressants in the elderly.

Authors:  Edoardo Spina; Maria Gabriella Scordo
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

5.  Selective serotonin re-uptake inhibiting antidepressants and the risk of overanticoagulation during acenocoumarol maintenance treatment.

Authors:  Martina Teichert; Loes E Visser; Andrė G Uitterlinden; Albert Hofman; Peter J Buhre; Sabine Straus; Peter A G M De Smet; Bruno H Stricker
Journal:  Br J Clin Pharmacol       Date:  2011-11       Impact factor: 4.335

6.  Warfarin and Antidepressants: Happiness without Hemorrhaging.

Authors:  Randy A Sansone; Lori A Sansone
Journal:  Psychiatry (Edgmont)       Date:  2009-07

7.  Efficacy and tolerability of pharmacotherapy for post-stroke depression: a network meta-analysis.

Authors:  Linghui Deng; Shi Qiu; Yan Yang; Lu Wang; Yuxiao Li; Jing Lin; Qiang Wei; Lu Yang; Deren Wang; Ming Liu
Journal:  Oncotarget       Date:  2018-01-03

8.  SSRI co-medication with NOAC or VKA does not increase hospitalisation for bleeding: A retrospective nationwide cohort study in Austria 2010-2015.

Authors:  Safoura Sheikh Rezaei; Martina Mittlböck; Bertholdt Reichardt; Michael Wolzt
Journal:  Int J Geriatr Psychiatry       Date:  2019-04-24       Impact factor: 3.485

9.  Bupropion-warfarin combination: a serious complication.

Authors:  Amar D Bavle; Akshay S Phatak
Journal:  Indian J Psychol Med       Date:  2013-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.